These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 16614124)

  • 21. Colorectal cancer screening: physician recommendation is influential advice to Marylanders.
    Gilbert A; Kanarek N
    Prev Med; 2005 Aug; 41(2):367-79. PubMed ID: 15917034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Test-retest reliability of colorectal testing questions on the Massachusetts Behavioral Risk Factor Surveillance System (BRFSS).
    Bradbury BD; Brooks DR; Brawarsky P; Mucci LA
    Prev Med; 2005 Jul; 41(1):303-11. PubMed ID: 15917026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal carcinoma screening procedure use among primary care patients.
    Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G
    Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of colorectal cancer stage among HMO members targeted for screening.
    Myers RE; Murray J; Weinberg D; McGrory G; Wolf T; Caveny J; Hanchak N; Schlackman N; Comis R
    Arch Intern Med; 1997 Sep; 157(17):2001-6. PubMed ID: 9308512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low uptake of colorectal cancer screening 3 yr after release of national recommendations for screening.
    McGregor SE; Hilsden RJ; Li FX; Bryant HE; Murray A
    Am J Gastroenterol; 2007 Aug; 102(8):1727-35. PubMed ID: 17437502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are gender differences in colorectal cancer screening rates due to differences in self-reporting?
    Griffin JM; Burgess D; Vernon SW; Friedemann-Sanchez G; Powell A; van Ryn M; Halek K; Noorbaloochi S; Grill J; Bloomfield H; Partin M
    Prev Med; 2009 Nov; 49(5):436-41. PubMed ID: 19765609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with perceived risk in automotive employees at increased risk of colorectal cancer.
    Vernon SW; Myers RE; Tilley BC; Li S
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):35-43. PubMed ID: 11205487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-reported colonoscopy screening in Austria.
    Haidinger G; Waldhoer T; Vutuc C
    Eur J Cancer Prev; 2008 Aug; 17(4):354-7. PubMed ID: 18562961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tailored navigation in colorectal cancer screening.
    Myers RE; Hyslop T; Sifri R; Bittner-Fagan H; Katurakes NC; Cocroft J; Dicarlo M; Wolf T
    Med Care; 2008 Sep; 46(9 Suppl 1):S123-31. PubMed ID: 18725824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Knowledge of colorectal cancer prevention in the Bavarian population above 50 years--survey in two districts].
    Loss J; Eichhorn C; Nagel E
    Gesundheitswesen; 2005 Jul; 67(7):455-60. PubMed ID: 16103968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
    Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
    Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
    Musil D; Tillich J
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer screening among men and women in the United States.
    Peterson NB; Murff HJ; Ness RM; Dittus RS
    J Womens Health (Larchmt); 2007; 16(1):57-65. PubMed ID: 17324097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan.
    Farmer MM; Bastani R; Kwan L; Belman M; Ganz PA
    Cancer; 2008 Mar; 112(6):1230-8. PubMed ID: 18266204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overcoming barriers to colorectal cancer screening tests.
    Lachter J; Leska-Aharoni T; Warum D; Eliakim R
    Isr Med Assoc J; 2008; 10(8-9):621-6. PubMed ID: 18847166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.